34. Pathological and immunohistochemical prognostic factors in clinically node-negative breast cancer patients receiving adjuvant tamoxifen (BR3002 trial)
Titel:
34. Pathological and immunohistochemical prognostic factors in clinically node-negative breast cancer patients receiving adjuvant tamoxifen (BR3002 trial)
Auteur:
Baker, P.R. Walker, R.A. Dunn, J.A. Parnell, S.M. Stonelake, P.S. Jevons, C.M. Gillespie, W.M. Baker, P.G. Dodson, L. Oates, G.D. Ellis, D.J. Lee, M.J.R. Morrison, J.M. Spooner, D.